Vor Biopharma Cash Flow Statement (2020-2026) | VOR

Cash Flow Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-19.07M-19.25M-18.97M-23.46M-22.98M-24.97M-26.63M-29.98M-30.43M-33.47M-28.66M-32.44M-27.91M-29.21M-32.40M-34.17M-283.94M-26.41M-33.27M-31.34M
Depreciation and Depletion (Quarter)
0.40M0.30M0.43M0.40M0.60M0.90M0.62M0.84M0.90M0.90M0.89M0.94M0.90M0.90M0.80M0.80M2.10M0.00M0.04M0.03M
Share-based Compensation (Quarter)
1.07M1.15M1.20M1.75M1.74M3.33M16.56M0.27M4.24M3.16M-10.28M0.18M2.79M2.26M1.71M1.93M1.84M8.03M15.83M8.87M
Gains from Investment Securities (Quarter)
1,299.92M790.46M-1756.02M188.36M
Cash from Operations (Quarter)
-16.57M-17.34M-17.59M-22.90M-24.99M-18.90M-18.35M-24.27M-24.10M-27.90M-24.03M-30.46M-21.85M-23.29M-24.06M-31.07M-35.18M-53.66M-22.80M-38.25M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) (Quarter)
0.40M0.30M0.43M0.40M0.60M0.90M0.62M0.84M0.90M0.90M0.89M0.94M0.90M0.90M0.80M0.80M2.10M0.00M0.04M0.03M
Change in Working Capital
Change in Accured Expenses (Quarter)
1.68M1.09M0.07M-0.72M-0.75M0.93M1.66M-0.09M0.11M2.66M0.17M-2.48M0.55M0.48M3.69M-1.37M1.10M5.00M6.21M-9.10M
Other Working Capital Changes (Quarter)
-1.12M-0.70M-0.72M-0.73M-6.31M-2.00M-1.42M-0.73M-1.00M-0.92M-0.94M-0.92M-0.92M-0.97M-1.02M-1.05M-1.28M-0.02M-0.06M-0.06M
Investing Activities
Capital Expenditures (Quarter)
-1.03M2.58M-2.53M2.01M5.83M-7.79M-0.02M0.00M0.49M0.47M-0.89M0.11M0.01M0.03M0.07M0.38M0.24M0.31M0.05M
Change in Acquisitions & Divestments (Quarter)
13.00M21.43M30.00M49.00M41.00M27.00M54.00M53.00M0.00M-0.00M5.00M13.31M
Cash from Investing Activities (Quarter)
-76.04M-8.49M-5.95M-7.05M-2.70M12.70M-97.04M6.50M13.64M40.54M10.34M43.97M52.99M-0.03M-0.07M-0.23M0.65M-0.24M-48.97M-263.24M
Financing Activities
Other financing activities (Quarter)
-188.95M188.95M0.20M0.10M0.23M0.01M174.40M75.00M
Change in Capital Stock
Shares Issued (Quarter)
2.62M2.48M5.09M2.55M1.91M0.43M6.47M1.15M0.67M0.97M8.29M3.13M1.89M2.46M0.46M2.99M7.51M1.74M6.61M7.02M
Net Equity Issued and Repurchased (Quarter)
3.84M0.11M3.62M0.58M0.39M-0.01M0.28M-0.09M0.11M-0.02M20.26M49.85M
Misc.
Cash from Financing Activities (Quarter)
-0.45M0.20M0.31M0.20M0.60M4.08M112.26M2.52M0.22M0.18M0.03M0.10M-0.03M0.04M53.29M-0.61M175.06M21.55M307.80M74.87M
Change in Cash (Quarter)
-93.05M-25.63M-23.23M-29.76M-27.09M-2.12M-3.12M-15.25M-10.24M12.81M-13.67M13.60M31.11M-23.28M29.15M-31.90M140.53M-32.36M236.02M-226.61M
Free Cash Flow (Quarter)
-15.54M-19.93M-15.05M-24.91M-30.82M-11.12M-18.33M-24.27M-24.59M-28.36M-23.14M-30.58M-21.86M-23.32M-24.14M-31.07M-35.57M-53.91M-23.11M-38.29M
Net Cash Flow (Quarter)
-93.05M-25.63M-23.23M-29.76M-27.09M-2.12M-3.12M-15.25M-10.24M12.81M-13.67M13.60M31.11M-23.28M29.15M-31.90M140.53M-32.36M236.02M-226.61M